Effect of Panax ginseng extract (G115) on angiotensin-converting enzyme (ACE) activity and nitric oxide (NO) production

Journal of Ethnopharmacology

Volumn 105, Issue 3, 2006, Pages 321-325

  Persson, Ingrid A L ^a   Dong, Linda ^a   Persson, Karin ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Angiotensin converting enzyme; HUVEC; Nitric oxide; Panax ginseng

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; ENALAPRILAT; GINSENG EXTRACT; NITRIC OXIDE;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; GINSENG; HUMAN; HUMAN CELL; INCUBATION TIME; MESENTERIC ARTERY; NONHUMAN; PHARMACODYNAMICS; SMOOTH MUSCLE RELAXATION; STATISTICAL SIGNIFICANCE;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; PANAX; PLANT EXTRACTS; VASODILATION;

ANIMALIA; ARALIACEAE; BOS TAURUS; PANAX GINSENG;

EID: 33646105367     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2005.10.030     Document Type: Article

References (30)

1. Ackermann A., Fernándes-Alfonso M.S., Sánchez de Rojas R., Ortega T., Paul M., and Gonzalez C. Modulation of angiotensin-converting enzyme by nitric oxide. British Journal of Pharmacology 124 (1998) 291-298
2. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clinical and Experimental Pharmacology and Physiology 23 (1996) 728-732
3. Chen X., Salwinski S., and Lee T.J. Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway. Clinical and Experimental Pharmacology and Physiology 24 (1997) 958-959
4. Chu G.X., and Chen X. Anti-lipid peroxidation and protection of ginsenosides against cerebral ischemia-reperfusion injuries in rats. Zhongguo Yao Li Xue Bao 11 (1990) 119-123
5. ESCOP Monograph, 2003. Ginseng Radix. In: ESCOP (Eds.), Georg Thieme Verlag, Stuttgart, pp. 211-222.
6. Fernándes-Alfonso M.S., and González C. Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems?. Journal of Hypertension 17 (1999) 1355-1361
7. Friedl R., Moeslinger T., Kopp B., and Spieckermann P.G. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. British Journal of Pharmacology 134 (2001) 1663-1670
8. Han S.W., and Kim H. Ginsenosides stimulate endogenous production of nitric oxide in rat kidney. International Journal of Biochemistry and Cell Biology 28 (1996) 573-580
9. Han K.H., Choe S.C., Kim H.S., Sohn D.W., Nam K.Y., Oh B.H., Lee M.M., Park Y.B., Choi Y.S., Seo J.D., and Lee Y.W. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. American Journal of Chinese Medicine 26 (1998) 199-209
10. Jacobsson L.S., Persson K., Aberg G., Andersson R.G.G., Karlberg B.E., and Olsson A.G. Anti-atherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic mini pigs. Journal of Cardiovascular Pharmacology 24 (1994) 670-677
11. Jeon B.H., Kim C.S., Park K.S., Lee J.W., Park J.B., Kim K.-J., Kim S.H., Chang S.J., and Nam K.Y. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. General Pharmacology 35 (2000) 135-141
12. Kang S.Y., Schini-Kerth V.B., and Kim N.D. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sciences 56 (1995) 1577-1586
13. Keifer D., and Pantuso T. Panax ginseng. American Family Physician 68 (2003) 1539-1542
14. Kim H., Chen X., and Gillis C.N. Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochemical and Biophysical Research Communication 189 (1992) 670-676
15. Kim N.D., Kang S.Y., and Schini V.B. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. General Pharmacology 25 (1994) 1071-1077
16. Kurz S., Hink U., Nickenig G., Borthayre A.B., Harrison D.G., and Munzel T. Evidence for a casual role of the angiotensin-converting enzyme by nitric oxide. British Journal of Pharmacology 124 (1999) 3181-3187
17. Lauer T., Preik M., Rassaf T., Strauer B.E., Deussen A., Feelisch M., and Kelm M. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proceedings of the National Academy of Sciences of the U.S.A. 98 (2001) 12814-12819
18. + channels in ginsenosides-induced aortic relaxation in rats. Journal of Cardiovascular Pharmacology 37 (2001) 41-47
19. Millatt L.J., Abdel-Rahman E.M., and Siragy H.M. Angiotensin II and nitric oxide; a question of balance. Regulatory Peptides 81 (1999) 1-10
20. Nyhlén K., Linden M., Andersson R.G.G., and Uppugunduri S. Corticosteroids and interferons inhibit cytokine induced production of IL-8 by human endothelial cells. Cytokine 12 (2000) 355-360
21. 2 receptors. Journal of Cardiovascular Pharmacology 31 (1998) 306-313
22. Persson K., and Andersson R.G.G. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries. European Journal of Pharmacology 385 (1999) 21-27
23. Persson K., Whiss P.W., Nyhlén K., Jacobsson-Strier M., Glindell M., and Andersson R.G.G. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro. European Journal of Pharmacology 406 (2000) 15-23
24. Rimar S., Lee-Mengel M., and Gillis C.N. Pulmonary protective vasodilator effects of a standardized Panax ginseng extract preparation following artificial gastric digestion. Pulmonary Pharmacology 9 (1996) 205-209
25. 1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. British Journal of Pharmacology 134 (2001) 1159-1165
26. Soldati F. Panax ginseng: standardization and biological activity. In: Cutler S.J., and Cutler H.J. (Eds). Biologically Active Natural Products: Pharmaceuticals (2000), CRC Press, Boca Raton 209-232
27. Sung J., Han K.H., Zo J.H., Park H.J., Kim C.H., and Oh B.H. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. American Journal of Chinese Medicine 28 (2000) 205-216
28. WHO, 1999. Monograph radix ginseng. In: WHO Monographs on Selected Medicinal Plants, vol. 1, World Health Organization, Geneva, pp. 168-182.
29. Yu C.T., Chen J., Teng X.W., Tong V., and Chang T.K.H. Lack of evidence for induction of CYP2B1, CYP3A23 and CYP1A2 gene expression by Panax ginseng and Panax quinquefolius extracts in adult rats and primary cultures of rat hepatocytes. Drug Metabolism and Disposition 33 (2005) 19-22
30. Zhu S., Zou K., Cai S., Meselhy M.R., and Komatsu K. Simultaneous determination of triterpene saponins in Ginseng drugs by high-performance liquid chromatography. Chemical Pharmaceutical Bulletin 52 (2004) 995-998